During the past decade, Univ. of Iowa Healthcare, Div. of Infectious Diseases conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. of Iowa Healthcare, Div. of Infectious Diseases" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Univ. of Iowa Healthcare, Div. of Infectious Diseases" are "HIV Infections" (17 trials), "Influenza" (5 trials), "Hepatitis C" (2 trials), "Cytomegalovirus Infections" (1 trials) and "H3N2 Influenza" (1 trials). Many other conditions were trialed in "Univ. of Iowa Healthcare, Div. of Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Univ. of Iowa Healthcare, Div. of Infectious Diseases" are "Drug" (21 trials), "Biological" (11 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (7 trials), "Didanosine" (6 trials), "Lamivudine" (5 trials), "Stavudine" (5 trials) and "Indinavir sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Univ. of Iowa Healthcare, Div. of Infectious Diseases" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Univ. of Iowa Healthcare, Div. of Infectious Diseases". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Univ. of Iowa Healthcare, Div. of Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ. of Iowa Healthcare, Div. of Infectious Diseases, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".